Fate Therapeutics
FATE
#8303
Rank
NZ$0.51 B
Marketcap
NZ$4.44
Share price
-8.83%
Change (1 day)
131.41%
Change (1 year)

Fate Therapeutics (FATE) - Net assets

Net assets on the balance sheet as of March 2026 : NZ$0.30 Billion

According to Fate Therapeutics 's latest financial reports the company has NZ$0.30 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Fate Therapeutics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$NZ$0.35 B-36.7%
2024-12-31$NZ$0.56 B-2.99%
2023-12-31$NZ$0.58 B-23.57%
2022-12-31$NZ$0.76 B-23.31%
2021-12-31$NZ$0.99 B86.53%
2020-12-31$NZ$0.53 B46.61%
2019-12-31$NZ$0.36 B51.91%
2018-12-31$NZ$0.23 B120.11%
2017-12-31$NZ$0.10 B2.91%
2016-12-31$NZ$0.10 B90.02%
2015-12-31$NZ$55.57 M53.65%
2014-12-31$NZ$36.17 M-41.54%
2013-12-31$NZ$61.87 M-196.36%
2012-12-31$-NZ$64.22 Million-1.12%
2011-12-31$-NZ$64.95 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Becton Dickinson
BDX
NZ$41.48 B 13,328.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.58 B 737.53%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-NZ$0.32 Billion-200.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$5.85 B 1,796.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$2.90 B 839.64%๐Ÿ‡บ๐Ÿ‡ธ USA